EBI3 Gene

EBI3 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">EBI3 Gene</th>
</tr>
<tr> [@kuestner2007]
<td class="label">Full Name</td>
<td>Epstein-Barr Virus Induced 3</td>
</tr>
<tr>
<td class="label">Symbol</td>
<td>EBI3</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q14213" target="_blank">Q14213</a></td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/10193" target="_blank">10193</a></td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>6</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Epstein-Barr virus-induced gene 3 protein</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>229 amino acids</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Immune cells (dendritic cells, B cells, macrophages); low in brain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), Autoimmune diseases, Multiple sclerosis</td>
</tr>
</table>

EBI3 Gene

Introduction

EBI3 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">EBI3 Gene</th>
</tr>
<tr> [@kuestner2007]
<td class="label">Full Name</td>
<td>Epstein-Barr Virus Induced 3</td>
</tr>
<tr>
<td class="label">Symbol</td>
<td>EBI3</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q14213" target="_blank">Q14213</a></td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/10193" target="_blank">10193</a></td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>6</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Epstein-Barr virus-induced gene 3 protein</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>229 amino acids</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Immune cells (dendritic cells, B cells, macrophages); low in brain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), Autoimmune diseases, Multiple sclerosis</td>
</tr>
</table>

EBI3 Gene

Introduction

The EBI3 gene (Epstein-Barr virus-induced gene 3) encodes a soluble cytokine receptor that is a component of the interleukin-27 (IL-27) and interleukin-35 (IL-35) cytokine complexes. Genetic variants in EBI3 have been associated with an increased risk of [Parkinson's disease](/diseases/parkinsons-disease) (PD) in genome-wide association studies (GWAS), suggesting a potential role for immune modulation in PD pathogenesis.

Overview

The [EBI3](/genes/ebi3) gene is located on chromosome 19p13.3 and encodes a 229-amino acid secreted protein [1]. Originally identified as an Epstein-Barr virus-induced gene in B lymphocytes, EBI3 is now recognized as an important immunoregulatory molecule that forms heterodimeric cytokines with other interleukin chains.

EBI3 has been implicated in:

• Parkinson's disease risk: GWAS-identified risk locus
• Autoimmune diseases: Multiple sclerosis, inflammatory bowel disease
• Cancer immunotherapy: Target for tumor treatment

Gene Structure

Genomic Organization

• Chromosomal location: 19p13.3
• Genomic span: ~4 kb
• Exons: 6
• Transcript length: ~1.5 kb mRNA
• Coding sequence: 690 bp

Common Genetic Variants

| SNP | Location | Risk Allele | PD Association | Reference |
|-----|----------|-------------|-----------------|-----------|
| rs4283217 | Intron | T | Increased risk | [2] |
| rs4299263 | Promoter | T | Altered expression | [3] |
| rs4744320 | 3'UTR | A | Modified risk | [4] |

Protein: EBI3

Structure

EBI3 is a member of the hematopoietin receptor family but lacks a transmembrane domain:

• Signal peptide: Secretory pathway
• N-terminal cytokine receptor domain: IL-12 family homology
• Fibronectin type III domain: Receptor structure
• Soluble form: Secreted protein

Isoforms

Multiple splice variants exist:

• Full-length (229 aa): Primary functional isoform
• Alternative splice forms: Some lack functional domains

Function

IL-27 Cytokine Complex

EBI3 pairs with IL-27 p28 (IL30) to form IL-27:

• IL-27: Pro-inflammatory cytokine
• Receptor: WSX-1 (TCCR) + gp130
• Signaling: JAK/STAT pathway (primarily STAT1, STAT3)

• Promotes T helper 1 (Th1) differentiation
• Inhibits Th17 cells
• Can have anti-inflammatory properties in some contexts

IL-35 Cytokine Complex

EBI3 also pairs with p35 (IL-12a) to form IL-35:

• IL-35: Anti-inflammatory cytokine
• Produced by: Regulatory T cells (Tregs)
• Function: Suppresses effector T cell responses

Expression Patterns

EBI3 is expressed in:

• Dendritic cells: High expression
• B lymphocytes: EBV-induced expression
• Macrophages: Inflammatory contexts
• Endothelial cells: Low levels
• [Neurons](/entities/neurons): Very low, may increase in disease

Role in Parkinson's Disease

GWAS Evidence

Multiple GWAS have identified EBI3 as a Parkinson's disease risk gene:

• The association was replicated in European and Asian populations
• The mechanism is still being elucidated
• May involve immune system modulation

Proposed Mechanisms

How EBI3 variants might contribute to PD:

• Modified IL-27/IL-35 balance
• Affects microglial activation
• May influence [alpha-synuclein](/proteins/alpha-synuclein) clearance

• Altered T cell function
• Modified cytokine responses
• Potential impact on peripheral immunity

• EBI3 may affect BBB integrity
• May influence immune cell trafficking

Neuroinflammation Connection

PD is characterized by chronic neuroinflammation:

• Microglial activation
• Pro-inflammatory cytokine release
• EBI3 variants may tip the balance toward pro-inflammatory state

Therapeutic Implications

EBI3 as Drug Target

• IL-27 modulators: Being developed for autoimmune disease
• EBI3-neutralizing antibodies: Potential immunomodulation
• Small molecule inhibitors: Research stage

PD Therapeutic Strategies

Potential approaches:

• Modulate IL-27 signaling
• Target EBI3 pathway for neuroprotection
• Combine with alpha-synuclein targeting

Research Directions

Current research areas:

• Functional validation of GWAS variants
• Understanding EBI3's role in CNS
• Developing pathway-specific therapies
• Biomarker development

Animal Models

• EBI3 knockout mice: Used to study immune function
• PD mouse models: Investigating EBI3 contributions
• Autoimmune models: Studying EBI3 in inflammation

Background

The study of Ebi3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [LRRK2 Gene](/genes/lrrk2)
• GBA Gene
• [SNCA Gene](/genes/snca)
• Neuroinflammation in PD
• IL-27 Signaling
• GWAS in Neurodegeneration